Lourens T. Bloem
Lourens T. Bloem publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Physiology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Biomedical Ethics and Regulation.
- World rank
- #1,088,535 of 7,710,434 ranked researchers
- Rank in Netherlands
- #25,219 of 107,149
- Works
- 60
- Citations
- 434
- Citations per work
- 7.2
What does Lourens T. Bloem research?
Lourens T. Bloem's work is mostly in Economics, Econometrics and Finance (38%), Medicine (22%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences2337.9%
- Everything else1931.3%
- Health Sciences1422.5%
- Medicine1422.5%
- Life Sciences58.3%
- 1Economics and Econometrics38% of their works
- 2Pulmonary and Respiratory Medicine8% of their works
- 3Physiology8% of their works
- 4Oncology7% of their works
- 5Molecular Biology5% of their works
- 6Toxicology4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biomedical Ethics and Regulation
- Economic and Financial Impacts of Cancer
- Pharmacovigilance and Adverse Drug Reactions
- Lung Cancer Treatments and Mutations
- Melanoma and MAPK Pathways
- Pharmaceutical and Antibiotic Environmental Impacts
Which keywords describe Lourens T. Bloem's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Drug Development Costs, Generic Drugs, Clinical Trials, Regulatory Challenges, Stem Cell Regulation and Cost of Care.
- MAP Kinase
- Antibiotics
- EGFR Mutations
- Adverse Drug Reactions
- Cost of Care
- Regulatory Challenges
- Generic Drugs
- Quality of Life
- Cost-effectiveness Analysis
- Drug Development Costs
- Clinical Trials
- Stem Cell Regulation
- Financial Toxicity
- Pharmacovigilance
- Targeted Therapy
- BRAF gene
- Resistance Genes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cost-effectiveness Analysis301 topic
- Quality of Life301 topic
- Drug Development Costs191 topic
- Generic Drugs191 topic
- Clinical Trials182 topics
- Regulatory Challenges131 topic
- Stem Cell Regulation131 topic
- Cost of Care121 topic
- Financial Toxicity121 topic
- Adverse Drug Reactions61 topic
- Pharmacovigilance61 topic
- EGFR Mutations51 topic
- Targeted Therapy51 topic
- Antibiotics41 topic
- BRAF gene41 topic
- MAP Kinase41 topic
- Resistance Genes41 topic
Where does Lourens T. Bloem work?
Lourens T. Bloem's main affiliation in the publication record is Utrecht University, Netherlands.
How many publications and citations does Lourens T. Bloem have?
OpenAlex counts 60 works and 434 citations for Lourens T. Bloem, an h-index of 12, ranking #1,088,535 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lourens T. Bloem. Posts are plain text and can be reported.